Class I · High riskTerminated Initiated Mar 28, 2024 (2 years ago)
Atovaquone Oral Suspension USP, 750 mg per 5 mL sachets, 20 Units x 5 mL cartons, Rx…
Class I — High risk. Reasonable probability of serious harm or death.
Why it was recalled
Microbial contamination of a non-sterile product: potential Bacillus cereus contamination.
What was recalled
Atovaquone Oral Suspension USP, 750 mg per 5 mL sachets, 20 Units x 5 mL cartons, Rx Only, Manufactured for: AvKARE, Pulaski, TN 38478, NDC 50268-086-12.
Recalling firm
AvKARE
NDC code
50268-086-12
Origin
TN, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0444-2024
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Reason Microbial Contamination of Non-Sterile Product: Objectionable organism, identified as Bacillus cereus, found in product during testing of repackaged…
Reason Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they…
Attix PharmaceuticalsD-528-2015
Get an alert if your medication is recalled
Tell us which medications you take. If the FDA recalls one, we email you - in plain English, with what to do. Free.